+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 19Years +
All Genders
ID06794294

Phase 12a Study to Assess Safety and Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cell Injection for Rotator Cuff Disease

Led by Seoul National University Hospital · Updated on 2026-04-29

21

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and exploratory effectiveness of allogenic umbilical cord-derived mesenchymal stem cell treatment in patients with rotator cuff disease. This open-label, single-center study includes adults aged 19 years and older who have a partial-thickness rotator cuff tear confirmed by MRI or ultrasound. The study is sponsored by Seoul National University Hospital and aims to better understand treatment options for patients who have not responded to conservative therapies. Participants will receive one injection of the stem cell treatment directly into the lesion using ultrasound guidance. The study tests three different dosages low, mid, and high doses of stem cells, each given only once during the study period. The treatment is designed to be administered by an investigator using a precise injection technique. Throughout the study, participants will undergo assessments including the Shoulder Pain and Disability Index SPADI score, Constant-Murley score, Visual Analog Scale VAS for pain during motion, and imaging evaluations using MRI and arthroscopy to track changes in the rotator cuff tear size. Safety is closely monitored by recording any adverse events over six months. Participants will be followed for this duration to evaluate treatment effects and safety outcomes.

CONDITIONS

Brief Title

Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease

Research Team

K

KeeJeong Bae, Principal Investigator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here